Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Long-term toxicity of early stages of Hodgkin's disease therapy: the EORTC experience. EORTC Lymphoma Cooperative Group.

× No keyword cloud information.

13 in total

Review 1. Hodgkin's lymphoma. II: Treatment and delayed morbidity.

Authors: P Carde
Journal: BMJ Date: 1992-07-18

Review 2. Nodular lymphocyte-predominant Hodgkin's lymphoma.

Authors: Lucia Nogovà; Volker Diehl; Andreas Engert
Journal: Curr Hematol Malig Rep Date: 2006-03 Impact factor: 3.952

3. Pregnancy-associated cardiomyopathy in survivors of childhood cancer.

Authors: Melissa R Hines; Daniel A Mulrooney; Melissa M Hudson; Kirsten K Ness; Daniel M Green; Scott C Howard; Matthew Krasin; Monika L Metzger
Journal: J Cancer Surviv Date: 2015-06-05 Impact factor: 4.442

4. Chemotherapy and Radiation Induced Pulmonary Dysfunction in Hodgkin Lymphoma Patients.

Authors: Sebnem Izmir Guner; Mustafa Teoman Yanmaz; Ahmet Selvi; Cigdem Usul
Journal: Indian J Hematol Blood Transfus Date: 2015-11-14 Impact factor: 0.900

5. [IF-RT alone remains gold standard for stage IA nodular lymphocyte-predominant Hodgkin lymphoma].

Authors: Karoline Pilz; Christina Jentsch; Mechthild Krause
Journal: Strahlenther Onkol Date: 2016-06 Impact factor: 3.621

6. Radiation induced coronary heart disease.

Authors: D Sebag-Montefiore; H Hope-Stone
Journal: Br Heart J Date: 1993-06

7. Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma.

Authors: Kheng-Wei Yeoh; N George Mikhaeel
Journal: Adv Hematol Date: 2010-10-24

8. Efficacy of dose escalation on TCP, recurrence and second cancer risks: a mathematical study.

Authors: V S K Manem; A Dhawan; M Kohandel; S Sivaloganathan
Journal: Br J Radiol Date: 2014-09-11 Impact factor: 3.039

9. Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL)-clinicopathological features based on the data of two Hungarian lymphoma centres.

Authors: A Illés; Zs Simon; E Tóth; A Rosta; Zs Miltényi; Zs Molnár
Journal: Pathol Oncol Res Date: 2008-04-23 Impact factor: 3.201

10. Modelling recurrence and second cancer risks induced by proton therapy.

Authors: V S K Manem; A Dhawan
Journal: Math Med Biol Date: 2018-09-11 Impact factor: 1.854